Latest Ratios: P/E Ratio -28.2x · EV/EBITDA 11.6x · ROE -14.8%. (2017–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $22.7B | $16.6B | $28.3B | $38.9B | $36.6B | $42.5B | $41.2B | $40.6B | — | — |
| Enterprise Value | $38.5B | $32.4B | $43.8B | $52.3B | $49.4B | $55.6B | $55.1B | $57.4B | — | — |
| P/E Ratio → | -28.23 | — | 25.56 | 66.88 | 8.02 | 6.77 | 33.84 | — | — | — |
| P/S Ratio | 0.53 | 0.42 | 0.66 | 0.87 | 0.64 | 0.77 | 1.07 | 0.95 | — | — |
| P/B Ratio | 1.28 | 0.95 | 1.59 | 2.03 | 1.72 | 2.27 | 3.17 | 2.88 | — | — |
| P/FCF | 22.57 | — | — | 14.30 | 6.75 | 7.71 | 8.51 | 10.26 | — | — |
| P/OCF | 21.98 | 16.12 | 9.71 | 7.48 | 4.89 | 6.06 | 6.62 | 6.85 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.81 | 1.02 | 1.17 | 0.87 | 1.01 | 1.43 | 1.34 | — | — |
| EV / EBITDA | 11.64 | 10.48 | 8.82 | 10.21 | 6.10 | 5.19 | 10.12 | 8.78 | — | — |
| EV / EBIT | 147.94 | — | 18.55 | 37.60 | 7.33 | 6.30 | 18.70 | — | — | — |
| EV / FCF | — | — | — | 19.25 | 9.12 | 10.10 | 11.39 | 14.50 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 6.0% | 6.0% | 10.4% | 11.1% | 13.8% | 18.9% | 12.5% | 13.9% | 13.5% | 25.8% |
| Operating Margin | 0.7% | 0.7% | 4.8% | 5.6% | 9.4% | 14.3% | 6.7% | 8.4% | 9.3% | 15.3% |
| Net Profit Margin | -6.6% | -6.6% | 2.6% | 1.3% | 8.1% | 11.5% | 3.2% | -3.2% | 7.5% | 1.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -14.8% | -14.8% | 6.0% | 2.9% | 22.9% | 39.8% | 9.0% | -6.5% | 16.4% | 1.7% |
| ROA | -4.5% | -4.5% | 1.9% | 1.0% | 7.4% | 10.1% | 2.0% | -2.0% | 5.7% | 0.6% |
| ROIC | 0.6% | 0.6% | 4.7% | 5.7% | 12.1% | 20.1% | 6.7% | 7.1% | 9.6% | 12.0% |
| ROCE | 0.5% | 0.5% | 4.3% | 5.2% | 10.8% | 15.8% | 5.1% | 6.3% | 8.6% | 10.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.12 | 1.12 | 0.99 | 0.86 | 0.79 | 0.86 | 1.46 | 1.36 | 0.71 | 0.78 |
| Debt / EBITDA | 6.33 | 6.33 | 3.56 | 3.21 | 2.07 | 1.50 | 3.50 | 2.93 | 2.34 | 2.27 |
| Net Debt / Equity | — | 0.90 | 0.87 | 0.70 | 0.60 | 0.70 | 1.07 | 1.19 | 0.61 | 0.55 |
| Net Debt / EBITDA | 5.10 | 5.10 | 3.12 | 2.63 | 1.58 | 1.23 | 2.56 | 2.57 | 2.02 | 1.60 |
| Debt / FCF | — | — | — | 4.95 | 2.37 | 2.39 | 2.88 | 4.24 | 8.11 | — |
| Interest Coverage | -1.90 | -1.90 | 3.11 | 1.89 | 10.35 | 12.82 | 3.36 | -0.32 | 4.54 | 3.87 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.97 | 1.97 | 1.61 | 1.77 | 1.81 | 1.58 | 1.72 | 1.57 | 1.84 | 1.89 |
| Quick Ratio | 1.25 | 1.25 | 0.98 | 1.16 | 1.19 | 1.02 | 1.20 | 0.99 | 1.16 | 1.31 |
| Cash Ratio | 0.42 | 0.42 | 0.25 | 0.30 | 0.34 | 0.23 | 0.46 | 0.22 | 0.21 | 0.43 |
| Asset Turnover | — | 0.68 | 0.75 | 0.77 | 0.94 | 0.87 | 0.63 | 0.71 | 0.78 | 0.55 |
| Inventory Turnover | 5.70 | 5.70 | 5.88 | 6.53 | 7.02 | 6.05 | 5.92 | 5.95 | 4.48 | 5.28 |
| Days Sales Outstanding | — | 60.62 | 58.31 | 54.10 | 49.74 | 63.44 | 69.98 | 64.20 | 54.71 | 100.57 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 6.7% | 9.0% | 6.9% | 5.1% | 5.5% | 4.9% | 5.0% | 5.1% | — | — |
| Payout Ratio | — | — | 176.2% | 334.8% | 43.8% | 32.8% | 169.1% | — | 82.5% | 695.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 3.9% | 1.5% | 12.5% | 14.8% | 3.0% | — | — | — |
| FCF Yield | 4.4% | — | — | 7.0% | 14.8% | 13.0% | 11.7% | 9.7% | — | — |
| Buyback Yield | 0.0% | 0.0% | 1.7% | 1.6% | 6.4% | 2.4% | 0.3% | 1.2% | — | — |
| Total Shareholder Yield | 6.7% | 9.0% | 8.7% | 6.7% | 11.8% | 7.2% | 5.3% | 6.4% | — | — |
| Shares Outstanding | — | $712M | $705M | $709M | $726M | $749M | $742M | $743M | $750M | $750M |
Includes 30+ ratios · 9 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying DOW stock.
Dow Inc.'s current P/E ratio is -28.2x. The historical average is 28.2x.
Dow Inc.'s current EV/EBITDA is 11.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 8.5x.
Dow Inc.'s return on equity (ROE) is -14.8%. The historical average is 8.6%.
Based on historical data, Dow Inc. is trading at a P/E of -28.2x. Compare with industry peers and growth rates for a complete picture.
Dow Inc.'s current dividend yield is 6.67%.
Dow Inc. has 6.0% gross margin and 0.7% operating margin.
Dow Inc.'s Debt/EBITDA ratio is 6.3x, indicating high leverage. A ratio above 4x may signal elevated financial risk.
Key Metrics
Top Statement Risk
Feedstock-spread volatility distorts earnings quality
Metrics are mathematically derived from official filings.
Margin Recovery Looks Spread-Driven, Not Structural
Dow's gross margin whipsawed from a 5.4% trough in 2025Q2 to 17.9% in 2026Q2 before settling at 12.2% in 2026Q3, per reported quarterly statements, with operating margin recovering to 6.6% — a swing that appears to reflect feedstock-spread recovery rather than structural pricing power.
The volatility itself is the signal: a 12-point gross margin swing within five quarters for a $50B-revenue producer points to ethane-to-polyethylene spread dynamics and inventory valuation effects, not durable mix or pricing gains. Normalized earning power is better read through the two-year operating margin average, roughly 2-3%, which implies that the 6.6% print in 2026Q3 may represent a mid-cycle recovery rather than a new plateau. Net margin of 4.1% also flatters versus the TTM figure of -6.6%, so trailing twelve-month comparisons should anchor any earnings-power discussion.
Returns Remain Below Cost of Capital
ROIC has recovered to 1.5% in 2026Q3 from -2.3% in 2025Q4, yet sits far below any plausible weighted average cost of capital for an asset-heavy chemical producer, according to Dow's reported return metrics, while ROE of 2.1% follows a -8.4% print.
Even at the stronger end of the observed range (1.5% ROIC in 2024Q2 and 2026Q3), Dow appears to be destroying economic value against an estimated 8-9% cost of capital, which suggests the current asset base is being under-utilized rather than compounding returns. The decomposition points to efficiency, not margin, as the binding constraint: asset turnover has held flat near 0.17-0.19 across all ten quarters, meaning the $23.7B net PP&E is generating roughly $0.18 of revenue per dollar regardless of the margin environment. Investors should monitor whether any improvement in ROIC comes from turnover recovery, which would signal genuine volume and utilization gains, rather than margin oscillation alone.
Working Capital Cycle Has Stretched
Dow's cash conversion cycle has widened to 83 days in 2026Q3 from 73 days in 2024Q2, per reported quarterly balance sheet data, as days payable outstanding held near 49 while both receivables and inventory stand at 66 days; asset turnover remains pinned near 0.18.
The 10-day extension in the conversion cycle appears driven by receivables build (DSO up from 59 to 66) rather than inventory mismanagement (DIO up from 60 to 66), suggesting pricing and collection terms have loosened to defend volumes in a soft demand environment. That said, the recent $590 million working capital release noted in cash flow statements implies the inventory drawdown phase may now be contributing to, rather than constraining, operating cash flow — a source that is unlikely to repeat. DPO holding in the high-40s versus a longer cycle indicates Dow is not stretching suppliers to fund the gap, which reads as a discipline positive but leaves the efficiency burden on asset productivity.
Coverage Recovers, Debt Load Steadies
Interest coverage rebounded to 4.04x in 2026Q3 from a negative -6.07x in 2025Q4, while debt to equity edged up to 1.07 on roughly $18.9 billion of total debt, as reported in Dow's quarterly filings; D/EBITDA of 13.44x still reflects a depressed earnings denominator.
The coverage trajectory is the more informative read than the headline 13.44x leverage multiple, since that denominator is calculated off trough EBITDA and would compress sharply toward the mid-single digits on a mid-cycle spread environment. Relative to peers, Dow's 1.07 debt-to-equity sits below LyondellBasell's 1.56 and Olin's 1.68, which suggests the balance sheet has more room than the sector average to absorb a prolonged downturn. The key vulnerability is that equity has shrunk to $16.2B from $18.3B over two years on retained losses and dividends, so any further negative equity mark would mechanically amplify reported leverage even with flat absolute debt.
Book Value Anchor vs. Earnings Volatility
Dow trades at 1.32x book and 0.59x sales with a 6.4% dividend yield, while trailing EV/EBITDA of 12.71x compresses to 6.97x on forward estimates, per current market data; the gap implies consensus models a substantial EBITDA rebound off trough levels.
The 0.59x price-to-sales multiple is near the low end versus the peer group (LyondellBasell trades materially higher on book at 2.10x despite negative returns), which appears to reflect the market's pricing of mid-cycle rather than current depressed earnings, per peer comparison data. Against Eastman at 15.8x forward earnings and a 6.7% ROIC, Dow's negative TTM P/E makes earnings-based comparison unusable and pushes valuation debates toward asset value and normalized cash generation. The 6.4% dividend yield warrants scrutiny given that the quarterly dividend was rebased down from roughly $490 million to $253 million; the yield is high partly because the payout was resized, not purely because the price is cheap.
Why Forward P/E Misreads a Cyclical
Dow's forward P/E of 13.45x is the ratio most often misapplied to this business, since it capitalizes earnings at one point in the chemical cycle; TTM P/E is negative at -8.84x, per current market data, making mid-cycle EV/EBITDA and spread-normalized returns the more durable lens.
The forward multiple obscures two things specific to Dow's model: earnings at the trough are inflated as a valuation base precisely when they are least representative, and equity-based metrics are distorted by the goodwill write-down of roughly $800 million and the retained-earnings erosion from $21.7B to $16.7B. A price-to-book of 1.32x looks optically cheap versus Tronox at 0.38x or Huntsman at 0.51x, but book value here is itself impaired and excludes the off-balance-sheet economics of non-consolidated JVs such as EQUATE and Sadara. The preferred analytical substitute is mid-cycle EV/EBITDA anchored to the polyethylene-to-ethane spread, cross-checked against ROIC versus cost of capital, with equity earnings from affiliates added back explicitly; investors should treat the 6.97x forward multiple as an implied spread normalization assumption that has not yet been verified by reported results.